On Tuesday, OptimizeRx Corp (NASDAQ: OPRX) opened higher 19.67% from the last session, before settling in for the closing price of $9.20. Price fluctuations for OPRX have ranged from $3.78 to $14.13 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 32.56% annually for the last half of the decade. Company’s average yearly earnings per share was noted 58.01% at the time writing. With a float of $16.86 million, this company’s outstanding shares have now reached $18.49 million.
In an organization with 129 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 64.13%, operating margin of -11.44%, and the pretax margin is -17.07%.
OptimizeRx Corp (OPRX) Insider Updates
A key investor’s attitude towards the stock of the Health Information Services industry is another important factor to consider. The insider ownership of OptimizeRx Corp is 8.84%, while institutional ownership is 62.47%. The most recent insider transaction that took place on Mar 14 ’25, was worth 2,443,761. In this transaction Director of this company bought 321,408 shares at a rate of $7.60, taking the stock ownership to the 389,452 shares. Before that another transaction happened on Dec 12 ’24, when Company’s CEO bought 20,000 for $5.01, making the entire transaction worth $100,220. This insider now owns 601,253 shares in total.
OptimizeRx Corp (OPRX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 58.01% per share during the next fiscal year.
OptimizeRx Corp (NASDAQ: OPRX) Trading Performance Indicators
Check out the current performance indicators for OptimizeRx Corp (OPRX). In the past quarter, the stock posted a quick ratio of 2.89. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.16. Likewise, its price to free cash flow for the trailing twelve months is 30.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.84, a number that is poised to hit 0.01 in the next quarter and is forecasted to reach 0.64 in one year’s time.
Technical Analysis of OptimizeRx Corp (OPRX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.47 million. That was better than the volume of 0.43 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 52.57%. Additionally, its Average True Range was 0.96.
During the past 100 days, OptimizeRx Corp’s (OPRX) raw stochastic average was set at 79.90%, which indicates a significant increase from 61.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 91.57% in the past 14 days, which was lower than the 102.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.17, while its 200-day Moving Average is $6.87. However, in the short run, OptimizeRx Corp’s stock first resistance to watch stands at $12.38. Second resistance stands at $13.74. The third major resistance level sits at $14.71. If the price goes on to break the first support level at $10.04, it is likely to go to the next support level at $9.08. Assuming the price breaks the second support level, the third support level stands at $7.71.
OptimizeRx Corp (NASDAQ: OPRX) Key Stats
There are currently 18,493K shares outstanding in the company with a market cap of 203.61 million. Presently, the company’s annual sales total 92,130 K according to its annual income of -18,660 K. Last quarter, the company’s sales amounted to 32,320 K and its income totaled 1,370 K.
